<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2369">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04656860</url>
  </required_header>
  <id_info>
    <org_study_id>17-19-490</org_study_id>
    <nct_id>NCT04656860</nct_id>
  </id_info>
  <brief_title>Juice Plus Supplement Clinical Trial</brief_title>
  <official_title>Encapsulated Fruit and Vegetable Juice Concentrates, Cognition, and Inflammation - A Randomized Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama, Tuscaloosa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of North Texas Health Science Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama, Tuscaloosa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to determine whether encapsulated fruit and vegetable juice&#xD;
      concentrates can improve biological indicators of cognitive and multiple dimensions of memory&#xD;
      and learning.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preventive interventions that delay the onset of mild cognitive impairment and benign&#xD;
      forgetfulness have the potential to delay or even prevent the onset of Alzheimer's disease.&#xD;
      However, few studies have examined the feasibility of Encapsulated Fruit and Vegetable Juice&#xD;
      Concentrates in robust clinical trials; this limitation prevents investigators from&#xD;
      determining the real value of these supplements. Therefore, we propose to enroll 150 adults&#xD;
      aged 55 and older to a 24-month randomized placebo-controlled trial. Participants enrolled in&#xD;
      the experimental condition will be encouraged to consume 6 Encapsulated Fruit and Vegetable&#xD;
      Juice Concentrates capsules per day and 33 grams of a soy-based beverage power per day, which&#xD;
      included 5 grams of fiber. Participants enrolled in the controlled condition will receive six&#xD;
      placebo capsules and encouraged to maintain an adequate diet. Primary outcomes will include&#xD;
      objective measures of cognition, and a panel of inflammatory markers, peptides, enzymes, and&#xD;
      other biological markers known to be associated with cognitive decline.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2020</start_date>
  <completion_date type="Anticipated">March 12, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 12, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to experimental or placebo controlled condition</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Both the investigator and the participants will be blinded to study conditions</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Interleukin -5</measure>
    <time_frame>Baseline, Year, 1, and Year 2.</time_frame>
    <description>Interleukin -5 pg/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in serum Amyloid A</measure>
    <time_frame>Baseline, Year, 1, and Year 2.</time_frame>
    <description>Serum Amyloid A pg/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Interleukin 6</measure>
    <time_frame>Baseline, Year, 1, and Year 2.</time_frame>
    <description>Interleukin 6 pg/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in C-reactive protein</measure>
    <time_frame>Baseline, Year, 1, and Year 2.</time_frame>
    <description>C-reactive protein pg/mL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Auditory Very Learning Test</measure>
    <time_frame>Baseline, 6-months, 12-months, 18-months, and 24-months</time_frame>
    <description>Computer automated verbal memory recognition task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroop Test</measure>
    <time_frame>Baseline, 6-months, 12-months, 18-months, and 24-months</time_frame>
    <description>Verbal interference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trial Making task</measure>
    <time_frame>Baseline, 6-months, 12-months, 18-months, and 24-months</time_frame>
    <description>Information processing speed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cognitive Impairment</condition>
  <condition>Alzheimer Disease, Early Onset</condition>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Juice Plus+</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will consume 6 capsules daily consisting of a combination of Juice Plus+ Garden Blend, Juice Plus+ Orchard Blend and Juice Plus+ Berry Blend. Participants will consume supplements for 24-months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will consume 6 capsules daily consisting of microcrystalline cellulose, rice starch, vegetarian capsule (cellulose), and magnesium stearate. Participants in this condition will receive 1-year of supplements after the study is completed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Juice Plus+</intervention_name>
    <description>Participants will receive encapsulated fruit and vegetable juice concentrates or a placebo for a 24-month period</description>
    <arm_group_label>Juice Plus+</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Men and women ≥55 years old will be eligible participants&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior neurological or psychiatric condition&#xD;
&#xD;
          -  Using medications or supplements that influence cognition or inflammation (e.g.,&#xD;
             nootropics, asprin, and Nonsteroidal anti-inflammatory drugs,),&#xD;
&#xD;
          -  Prior cancer diagnosis,&#xD;
&#xD;
          -  Major respiratory, kidney, liver, and gastrointestinal issues&#xD;
&#xD;
          -  Currently enrolled in a weight loss program or taking an appetite suppressant;&#xD;
&#xD;
          -  Current smokers or excessive alcohol users&#xD;
&#xD;
          -  Consume &gt;= 4 servings of fruits and vegetables per day&#xD;
&#xD;
               -  Participate in &gt;= 90 minutes of purposeful physical activity per week&#xD;
&#xD;
               -  Do not have a mobile phone&#xD;
&#xD;
               -  Do not have a data plan or regular wireless network&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raheem Paxton, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raheem Paxton, PhD</last_name>
    <phone>205-348-6857</phone>
    <email>rpaxton@ua.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama, North East Medical Building</name>
      <address>
        <city>Tuscaloosa</city>
        <state>Alabama</state>
        <zip>35487</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raheem Paxton, PhD</last_name>
      <phone>205-348-6857</phone>
      <email>rpaxton@ua.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Tuscaloosa</city>
        <state>Alabama</state>
        <zip>35487</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raheem Paxton, PhD</last_name>
      <phone>205-348-6857</phone>
      <email>rpaxton@ua.edu</email>
    </contact>
    <contact_backup>
      <last_name>Raheem Paxton, PhD</last_name>
      <phone>204-348-6857</phone>
      <email>rpaxton@ua.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 3, 2020</study_first_submitted>
  <study_first_submitted_qc>December 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2020</study_first_posted>
  <last_update_submitted>April 5, 2021</last_update_submitted>
  <last_update_submitted_qc>April 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fruits and Vegetables</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Cognition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual data will not be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

